Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
8.93
Dollar change
+0.05
Percentage change
0.56
%
IndexRUT P/E- EPS (ttm)-0.16 Insider Own10.14% Shs Outstand143.11M Perf Week0.79%
Market Cap1.29B Forward P/E15.18 EPS next Y0.59 Insider Trans-0.19% Shs Float128.66M Perf Month18.75%
Income-22.55M PEG- EPS next Q0.03 Inst Own38.47% Short Float5.35% Perf Quarter29.99%
Sales220.36M P/S5.83 EPS this Y105.86% Inst Trans4.29% Short Ratio5.61 Perf Half Y68.49%
Book/sh2.71 P/B3.29 EPS next Y1757.87% ROA-4.08% Short Interest6.88M Perf Year0.90%
Cash/sh2.42 P/C3.69 EPS next 5Y- ROE-5.78% 52W Range4.71 - 9.74 Perf YTD-0.67%
Dividend Est.- P/FCF44.71 EPS past 5Y6.35% ROI-4.90% 52W High-8.32% Beta1.26
Dividend TTM- Quick Ratio5.11 Sales past 5Y3168.98% Gross Margin87.25% 52W Low89.60% ATR (14)0.31
Dividend Ex-Date- Current Ratio5.60 EPS Y/Y TTM71.17% Oper. Margin-7.13% RSI (14)65.14 Volatility3.74% 4.28%
Employees300 Debt/Eq0.23 Sales Y/Y TTM38.72% Profit Margin-10.23% Recom1.43 Target Price10.84
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q204.68% Payout- Rel Volume0.98 Prev Close8.88
Sales Surprise17.90% EPS Surprise566.67% Sales Q/Q24.32% EarningsNov 07 BMO Avg Volume1.23M Price8.93
SMA204.12% SMA5015.32% SMA20044.53% Trades Volume1,195,967 Change0.56%
Date Action Analyst Rating Change Price Target Change
Nov-04-22Downgrade Oppenheimer Outperform → Perform
May-05-22Resumed Cantor Fitzgerald Overweight $34 → $25
Dec-10-21Upgrade Oppenheimer Perform → Outperform $33 → $31
Oct-28-21Downgrade Oppenheimer Outperform → Perform $32
Jan-25-21Reiterated H.C. Wainwright Buy $30 → $35
Nov-03-20Reiterated H.C. Wainwright Buy $34 → $28
Jun-17-20Initiated BTIG Research Buy $20
May-05-20Initiated Cowen Outperform
Jan-10-20Initiated Jefferies Buy $27
Dec-16-19Reiterated H.C. Wainwright Buy $25 → $32
Nov-18-24 05:53PM
Nov-15-24 06:00AM
Nov-14-24 06:00AM
Nov-08-24 10:30AM
06:37AM
02:12AM Loading…
02:12AM
Nov-07-24 07:40AM
06:41AM
06:10AM
06:00AM
Oct-30-24 04:05PM
06:00AM
Oct-11-24 06:00AM
Sep-24-24 08:10AM
Sep-13-24 06:00AM
07:02PM Loading…
Sep-12-24 07:02PM
04:05PM
Sep-06-24 06:32AM
Sep-05-24 06:00AM
Aug-28-24 06:00AM
Aug-22-24 10:09AM
Aug-13-24 08:00AM
Aug-01-24 07:10AM
06:14AM
06:00AM
Jul-19-24 06:00AM
Jul-12-24 04:39AM
Jul-11-24 03:27PM
Jul-02-24 06:00AM
Jun-17-24 04:46AM
12:16PM Loading…
Jun-14-24 12:16PM
Jun-05-24 06:00AM
Jun-04-24 05:30PM
Jun-03-24 06:30PM
May-30-24 06:00AM
May-14-24 06:00AM
May-09-24 06:00AM
May-07-24 09:55AM
06:00AM
May-03-24 01:02PM
May-02-24 10:56AM
07:10AM
06:10AM
06:00AM
May-01-24 06:00AM
Apr-30-24 06:00AM
Apr-16-24 10:48AM
Apr-15-24 06:00AM
Apr-09-24 06:00AM
Mar-17-24 05:20PM
Feb-29-24 08:30AM
Feb-27-24 08:30AM
Feb-16-24 09:22AM
Feb-15-24 07:25AM
06:49AM
06:32AM
06:19AM
06:10AM
06:07AM
06:00AM
Feb-08-24 10:00AM
Feb-05-24 08:30AM
Jan-18-24 04:30PM
Jan-05-24 06:00AM
Dec-28-23 09:40AM
Dec-20-23 06:00AM
Dec-10-23 06:59AM
Nov-23-23 09:55AM
Nov-20-23 09:40AM
Nov-13-23 06:00AM
Nov-07-23 10:30AM
09:55AM
Nov-03-23 09:40AM
08:46AM
Nov-02-23 06:00PM
07:50AM
07:15AM
06:10AM
06:00AM
Oct-26-23 03:00PM
Oct-19-23 10:31AM
06:00AM
Oct-16-23 09:29AM
Oct-14-23 01:15PM
Oct-13-23 12:00PM
Oct-12-23 12:13PM
Oct-11-23 10:15AM
Oct-09-23 11:10AM
Oct-06-23 09:24AM
Oct-04-23 08:17AM
Oct-03-23 07:43AM
Sep-29-23 09:40AM
Sep-27-23 09:34AM
Sep-26-23 10:56AM
Sep-21-23 06:00AM
Sep-18-23 08:52AM
Sep-06-23 09:55AM
Aug-25-23 09:40AM
Aug-21-23 06:00AM
Aug-03-23 07:15AM
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey Jeffrey AllenDirectorNov 11 '24Sale8.434,55738,41613,356Nov 12 07:29 PM
Smith Karen L.DirectorNov 11 '24Sale8.435,24144,18212,672Nov 12 07:20 PM
Habig Scott MichaelChief Commercial OfficerAug 06 '24Sale5.3118,24996,902456,338Aug 08 04:06 PM
Balakrishnan BrindaDirectorMay 21 '24Sale5.745202,98517,523May 22 04:16 PM
Billen DanielDirectorMay 21 '24Sale5.745,25230,14628,141May 22 04:14 PM
Jayne David R.W.DirectorMay 21 '24Sale5.744,94628,39044,364May 22 04:11 PM
Leversage JillDirectorMay 21 '24Sale5.745,61032,20112,918May 22 04:09 PM
MacKay-Dunn R. HectorDirectorMay 21 '24Sale5.745,63032,31618,595May 22 04:07 PM
Greenleaf PeterChief Executive OfficerMar 06 '24Sale5.60126,981711,0941,522,114Mar 07 04:46 PM
Miller Joseph MChief Financial OfficerMar 06 '24Sale5.6034,811194,942495,928Mar 07 04:44 PM
Donley Matthew MaxwellEVP, Ops & StrategyMar 06 '24Sale5.5140,665224,064584,072Mar 07 04:43 PM
Habig Scott MichaelChief Commercial OfficerMar 06 '24Sale5.6017,77799,551474,587Mar 07 04:42 PM
Robertson Stephen P.EVP, General CounselMar 06 '24Sale5.6057,745323,372443,824Mar 07 04:41 PM
Knappertz VolkerEVP, Research and DevelopmentFeb 27 '24Sale6.104,93030,073319,128Feb 29 04:11 PM
Knappertz VolkerEVP, Research and DevelopmentFeb 20 '24Sale5.4825,146137,800324,058Feb 22 04:35 PM
Habig Scott MichaelChief Commercial OfficerFeb 20 '24Sale5.4815,86786,951492,364Feb 22 04:33 PM